EMA — authorised 19 November 2012
- Marketing authorisation holder: medac Gesellschaft für klinische Spezialpräparate mbH
- Status: approved
🇪🇺 Xeloda in European Union
EMA authorised Xeloda on 19 November 2012
Marketing authorisation
Xeloda in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Xeloda approved in European Union?
Yes. EMA authorised it on 19 November 2012.
Who is the marketing authorisation holder for Xeloda in European Union?
medac Gesellschaft für klinische Spezialpräparate mbH holds the EU marketing authorisation.